The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations

Journal Title: Journal of Dermatology Research - Year 2022, Vol 3, Issue 1

Abstract

Despite the revolution represented by biologic drugs, it is safe to say that every dermatologist has known the frustrating experience of treating a “difficult” patient with psoriasis. Such patients may have been treated with numerous drugs, never achieving long-term disease control. We hereby present the case of a patient who, despite having been treated, over the course of 15 years, with 7 biologics and 3 traditional systemic agents, has never experienced lasting remission. We also discuss hypothetical reasons for these repeated treatment failures: while obesity and ANA positivity could have contributed significantly, a third, more complex, factor may be to blame. It is possible that frequently switching to the newest drug available, due to lack of other therapeutic options, interfered with the pathogenetic phenotype of the patient, and, consequently, with the response to other biologics. This disheartening and fascinating hypothesis clearly needs to be investigated, in the hope of finding solutions for all seemingly impossible-to-treat patients.

Authors and Affiliations

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1

Keywords

Related Articles

Tattooing in Young Adults: Patterns, Complications and Reasons for Dermatological Consultation at a Tertiary Care Center

Background: A tattoo is a dermatological procedure in which pigmented dyes are injected into the dermis using needles or a tattooing device, leading to permanent or semi-permanent skin pigmentation. This process may trig...

Silicone Granulomas: The Good, the Bad, the Ugly

Liquid Injectable Silicone (LIS) has become a widely utilized material in various cosmetic interventions such as body contouring and enhancement. While these applications often yield positive aesthetic and functional out...

Sézary Syndrome as an Etiological Cause of Erythroderma: A Case Report

Exfoliative erythroderma is a syndrome characterized by erythema and scaling that affects more than 90% of the body surface. In contrast, Sézary Syndrome is a rare and harmful variant of cutaneous T-cell lymphoma, define...

Post COVID - 19 Infection Diffuse Patch Granuloma Annulare in a Female Patient with Rheumatoid Arthritis: A Case Report

Introduction: Granuloma Annulare (GA) is a benign, usually self-limited, inflammatory granulomatous skin disorder of unknown etiology and with a diversity of clinical variants. Genetic factors, associations with predispo...

Flattened Nose Revealing Syphilitic Aortitis

Flattened nose also called syphilis nose is a deformation of the nose due to the destruction of the cartilage of the nasal septum: the lower segment of the nose collapses, undergoes recoil and retract, becoming embedded...

Download PDF file
  • EP ID EP702452
  • DOI http://dx.doi.org/10.46889/JDR.2022.3102
  • Views 76
  • Downloads 0

How To Cite

Martina Burlando1*, Ilaria Salvi1, Emanuele Cozzani1, Aurora Parodi1 (2022). The Risk of Creating Difficult-To-Treat Psoriasis by Switching Multiple Biologic Therapies: A Case Report and Relative Considerations. Journal of Dermatology Research, 3(1), -. https://europub.co.uk/articles/-A-702452